Structural and Functional Comparison of the RING Domains of Two p53 E3 Ligases, Mdm2 and Pirh2

被引:30
作者
Shloush, Jonathan
Vlassov, John E.
Engson, Ian
Duan, Shili [2 ]
Saridakis, Vivian
Dhe-Paganon, Sirano [3 ]
Raught, Brian [2 ]
Sheng, Yi [1 ]
Arrowsmith, Cheryl H. [2 ]
机构
[1] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada
[2] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada
关键词
UBIQUITIN-PROTEIN LIGASE; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; DNA-DAMAGE; COMPLEX; PATHWAY; CANCER; RESCUE; ANTAGONISTS;
D O I
10.1074/jbc.M110.157669
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 maintains genome stability and prevents malignant transformation by promoting cell cycle arrest and apoptosis. Both Mdm2 and Pirh2 have been shown to ubiquitylate p53 through their RING domains, thereby targeting p53 for proteasomal degradation. Using structural and functional analyses, here we show that the Pirh2 RING domain differs from the Mdm2 RING domain in its oligomeric state, surface charge distribution, and zinc coordination scheme. Pirh2 also possesses weaker E3 ligase activity toward p53 and directs ubiquitin to different residues on p53. NMR and mutagenesis studies suggest that whereas Pirh2 and Mdm2 share a conserved E2 binding site, the seven C-terminal residues of the Mdm2 RING directly contribute to Mdm2 E3 ligase activity, a feature unique to Mdm2 and absent in the Pirh2 RING domain. This comprehensive analysis of the Pirh2 and Mdm2 RING domains provides structural and mechanistic insight into p53 regulation by its E3 ligases.
引用
收藏
页码:4796 / 4808
页数:13
相关论文
共 62 条
[1]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[2]   THE PROGRAM XEASY FOR COMPUTER-SUPPORTED NMR SPECTRAL-ANALYSIS OF BIOLOGICAL MACROMOLECULES [J].
BARTELS, C ;
XIA, TH ;
BILLETER, M ;
GUNTERT, P ;
WUTHRICH, K .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (01) :1-10
[3]   THE SOLUTION STRUCTURE OF THE RING FINGER DOMAIN FROM THE ACUTE PROMYELOCYTIC LEUKEMIA PROTO-ONCOPROTEIN PML [J].
BORDEN, KLB ;
BODDY, MN ;
LALLY, J ;
OREILLY, NJ ;
MARTIN, S ;
HOWE, K ;
SOLOMON, E ;
FREEMONT, PS .
EMBO JOURNAL, 1995, 14 (07) :1532-1541
[4]   BRCA1 RING domain cancer-predisposing mutations - Structural consequences and effects on protein-protein interactions [J].
Brzovic, PS ;
Meza, JE ;
King, MC ;
Klevit, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41399-41406
[5]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[6]   Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b [J].
Buchwald, Gretel ;
van der Stoop, Petra ;
Weichenrieder, Oliver ;
Perrakis, Anastassis ;
van Lohuizen, Maarten ;
Sixma, Titia K. .
EMBO JOURNAL, 2006, 25 (11) :2465-2474
[7]   ARF-BP1/mule is a critical mediator of the ARF tumor suppressor [J].
Chen, DL ;
Kon, N ;
Li, MY ;
Zhang, WZ ;
Qin, J ;
Gu, W .
CELL, 2005, 121 (07) :1071-1083
[8]   p53's believe it or not: Lessons on transcription-independent death [J].
Chipuk, JE ;
Green, DR .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (05) :355-361
[9]   E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages [J].
Christensen, Devin E. ;
Brzovic, Peter S. ;
Klevit, Rachel E. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (10) :941-948
[10]   TANDEM: matching proteins with tandem mass spectra [J].
Craig, R ;
Beavis, RC .
BIOINFORMATICS, 2004, 20 (09) :1466-1467